共 24 条
Partial Least Squares Analysis and Mixture Design for the Study of the Influence of Composition Variables on Lipidic Nanoparticle Characteristics
被引:16
作者:
Malzert-Freon, A.
[1
]
Hennequin, D.
[2
]
Rault, S.
[1
]
机构:
[1] Univ Caen Basse Normandie, UFR Sci Pharmaceut, FR CNRS INC3M 3038, Ctr Etud & Rech Medicament Normandie,UPRES EA 425, F-14032 Caen, France
[2] Univ Caen, IUT UFR Sci, Equipe Rech Physicochim & Biotechnol ERPCB EA 391, F-14032 Caen, France
关键词:
nanoparticles;
partial least squares;
mixture design;
Labrasol (R);
size;
MULTIVARIATE-ANALYSIS;
PHASE INVERSION;
NANO-EMULSIONS;
EMULSIFIER;
DELIVERY;
MICROEMULSION;
FORMULATION;
GENTAMICIN;
ABSORPTION;
ADSORBENT;
D O I:
10.1002/jps.22177
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Lipidic nanoparticles (NP), formulated from a phase inversion temperature process, have been studied with chemometric techniques to emphasize the influence of the four major components (Solutol (R), Labrasol (R), Labrafac (R), water) on their average diameter and their distribution in size. Typically, these NP present a monodisperse size lower than 200 nm, as determined by dynamic light scattering measurements. From the application of the partial least squares (PLS) regression technique to the experimental data collected during definition of the feasibility zone, it was established that NP present a core-shell structure where Labrasol (R) is well encapsulated and contributes to the structuring of the NP. Even if this solubility enhancer is regarded as a pure surfactant in the literature, it appears that the oil moieties of this macrogolglyceride mixture significantly influence its properties. Furthermore, results have shown that PLS technique can be also used for predictions of sizes for given relative proportions of components and it was established that from a mixture design, the quantitative mixture composition to use in order to reach a targeted size and a targeted polydispersity index (PDI) can be easily predicted. Hence, statistical models can be a useful tool to control and optimize the characteristics in size of NP. (C) 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:4603-4615, 2010
引用
收藏
页码:4603 / 4615
页数:13
相关论文